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Abstract
Background: It is well documented that food handlers harbor and shed enteric foodborne pathogens causing
foodborne disease outbreaks. However, little known on enteric antibiotic resistant (AR) bacteria carriage in food
handlers. The objective of this study was to establish a baseline prevalence of fecal AR E. coli among food handlers
in Qatar.
Methods: Fecal samples were collected from 456 migrant food handlers of different nationalities arriving in Qatar
on a work permit between January 2015 and December 2016. These samples (25 g each) were collected based on
the availability and examination schedule at the Medical Commission facility from those consented to participate.
Isolated E. coli bacteria were tested for antibiotic susceptibility against nine antibiotics using the E-test method and
Double Disc Synergy Test (DDST) for extended-spectrum beta-lactamase (ESBL) production.
Results: From the 78 E. coli positive samples (17.1%, n = 456), 60% of the isolates were resistant to at least one
antibiotic, whereas, 27% were multi-drug resistant (MDR). Seven isolates (9%, n = 78) were ESBL producers of which
five were MDR. Individual AR E. coli frequencies to the nine antibiotics were not significantly (P > 0.05) different by
nationality.
Conclusions: Based on our findings, we revealed that individual resistant E. coli and MDR resistant E. coli were
common in fecal samples of food handlers in Qatar. This may indicate that food handlers can potentially
contaminate foods with AR E. coli, a possible public health concern.
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Background
Antibiotic resistance (AR) continues to pose a great
threat to public health in both developed and developing
countries [1, 2]. Infections caused by AR bacteria, espe-
cially multi-drug resistant organisms, can lead to serious
health problems such as prolonged hospitalization, treat-
ment failure and deaths [1, 2]. A worrying increase in
multi-drug resistant phenotypes in enterobacteriaceae
including E. coli and particularly to third-generation ceph-
alosporins as well as to colistin (last resort antibiotic used
to treat carbapenem-resistant enterobacteriaceae) has
been reported [3–8]. The emergence, development, and
spread of AR bacteria is a complex issue that involves
multiple factors such as the use and misuse of antibiotics,
poor infection control practices, inadequate sanitary con-
ditions, and inappropriate food-handling practices [9–12].
Accordingly, food handlers with poor personal hygiene
and inadequate food safety knowledge working in food
service establishments can be a potential source for food
contamination that can lead to foodborne disease and out-
breaks [13, 14]. Likewise, food handlers who harbor AR
bacteria in their gastrointestinal tract may contaminate
foods which is considered as a potential route AR bacteria
transmission to consumers [15].
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Food handlers have been linked to a large number of
foodborne outbreaks worldwide. A total of 816 food-
borne outbreaks with 80,682 foodborne illnesses oc-
curred between 1927 and 2006 were linked to food
handlers (Greig et al., 2007). Likewise, The Centre for
Disease Control and Prevention (CDC) revealed that
52% of 9040 foodborne disease outbreaks reported be-
tween 1998 and 2004 were associated with food services
(i.e., restaurants, cafeterias, and hotels) [16]. Approxi-
mately, bacterial agents caused 13% of these outbreaks.
The majority of foodborne outbreaks associated with
food services were associated with unsanitary conditions
of the food handlers [17, 18].
Escherichia coli bacteria are very abundant in the
human gastrointestinal tract and can serve as carriers/
reservoirs of AR genes. These bacteria are also able to
share AR genetic material with their fellow bacteria of
the same and/or different species [19, 20]. The incidence
of AR bacteria are rapidly increasing in humans in Qatar
(Personal communication with the Microbiological diag-
nostic Laboratory of Hamad Medical Corporation, Doha,
Qatar). A hospital-based AR bacteria surveillance system
exists in Qatar to monitor the incidence of a number of
AR bacteria from outpatient and in-patient clinics
(Hamad Medical Corporation, Doha, Qatar). However,
there is no available information on the AR enteric bac-
teria such as E. coli from non-clinical samples [21–23].
There is a large and continuous influx of migrant labor
workers in Qatar; largely from south-east Asian coun-
tries [24]. A group of those migrant workers comes to
Qatar on a work permit designated for jobs within the
food industry such as food handling and service. Many
of the food handlers have limited knowledge of risks as-
sociated with food contamination. Nonetheless, they
may harbor and shed AR commensal E. coli during
handling of food leading to food contamination. Hence,
resistant bacteria can spread to the public through con-
sumption of contaminated food. Research studies have
shown that multi-drug resistant E. coli can be present in
‘healthy’ individual in community settings [25–29] even
with the absence of antibiotic use [30]. Furthermore,
several studies have revealed that AR E. coli from food
source can spread to humans, colonize human gut, and
potentially cause infections such as urinary tract infec-
tions [31–35].
There is currently limited information on AR pheno-
types in commensal enteric organisms, from non-clinical
human populations in Qatar. A first step to assess the
AR risk associated with food handlers is to obtain a
baseline prevalence of AR E. coli (an indicator organism)
in fecal samples collected from this cohort. Therefore,
the objective of this study was to determine the
prevalence of the AR E. coli isolates from fecal samples
of migrant food handlers in Qatar.
Methods
Study population and sampling scheme
All migrant workers including food handlers arriving to
Qatar on work permit have to go through a mandatory
medical screening at the Medical Commission, Department
of Ministry of Public Health, Doha, Qatar [36]. Individual
fecal samples were collected randomly from apparently
healthy food handlers within one week of arrival to Qatar.
The collection of the fecal samples was conducted between
January 2015 and December 2016 as part of another re-
search study that focused on presence of enteric parasites
(Abu Madi et al., College of Health Sciences, Qatar Univer-
sity). All participants were provided with informed consent
form explaining the purpose of the study and clearly reas-
sured no obligation to participate; moreover, they have been
comforted that all collected data will be treated with high
confidentiality. The fecal samples (25 g each) were collected
based on the availability and examination schedule at the
Medical Commission Department from those consented to
participate. Nationality information was obtained for each
food handler. Portions of the fecal samples were used for
the parasite analysis, while the leftover samples (~ 10 g)
were stored in the freezer at − 20 °C. For this study, all
available frozen fecal samples (n = 456) representing 456
food handlers collected over two year period (January 2015
to December 2016) were used i. These samples were uti-
lized for E. coli isolation and antibiotic susceptibility testing.
The food handlers included in this study were all males be-
tween the ages of 20 and 35 year old. There were 139, 118,
110, 40, 25, 16, 5, and 3 fecal samples from food handlers
that originated from India, Bangladesh, Nepal, Philippine,
Sir Lanka, Indonesia, Kenya, and Thailand, respectively.
There were no reports of acute or chronic infections in the
food handlers. No additional identifiable information were
available for this study. Moreover, historical antibiotic use
data associated with the study subjects were not available.
The Institutional Review Board (IRB) of Ministry of Public
Health (Doha, Qatar) approved this study in June 2017.
E. coli isolation and identification
To isolate E. coli, fecal samples were thawed at room
temperature (25 °C), streaked directly onto a selective
medium CHROMagar™ E. coli plates (Difco, Becton
Dickenson, Sparks, MD) using sterile cotton-tipped
swabs, and then incubated at 37 °C for 18–24 h. A typ-
ical E. coli colony (green color with smooth surface) was
randomly selected and subsequently streaked onto 5%
sheep blood agar (Difco, BD) plates, then incubated at
37 °C for 18–24 h to obtain pure single colonies. For
confirmation, suspected E. coli colonies were transferred
onto MacConkey agar (Difco, BD) plates and incubated
(37 °C, 18–24 h). Thereafter, colonies were streaked onto
fresh blood agar plates and incubated (37 °C, 18–24 h)
for isolation. Up to three colonies from the blood agar
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were tested for lactose fermentation using the Indole
spot test (Remel, Thermoscientific, Lenexa, KS, USA).
Escherichia coli isolates were transferred to Cryovial
tubes (TechnicalService, Lancashire, U.K.) and stored at
− 80 °C until further analysis.
Antibiotic susceptibility testing of E. coli isolates
Frozen E. coli isolates were revived from the Cryovials
on blood agar plates. A single E. coli isolate was ran-
domly selected from the blood agar plate and suspended
in 0.85% saline (Difco, BD) to achieve an inoculum
equivalent to 0.5 McFarland standard as measured by
DensiCHEK™ Plus spectrophotometer (Biomérieux,
Marcy, France). The suspension was swabbed on a
Mueller-Hinton agar plate (MH; Difco, BD) using a ste-
rile cotton-tip and allowed to dry completely at room
temperature. An antibiotic susceptibility test strip (E-test
strip, BioMerieux) was then applied to the MH agar sur-
face with sterile forceps and the plate was incubated at
37 °C for 18–24 h. Thereafter, the minimum inhibitory
concentration (MIC) was read directly from the test
strip where the elliptical zone of inhibition intersected
with the MIC scale on the strip, according to the manu-
facturer’s instructions. The MIC values were interpreted
according to the Clinical & Laboratory Standards Insti-
tute (CLSI) guidelines [37]. Escherichia coli strains
ATCC® 25,922 and 35,218 were used as controls. The
nine antibiotics utilized for antibiotic susceptibility test-
ing of E. coli isolates and their breakpoints are shown in
Table 1.
Double disc synergy test (DDST)
All E. coli isolates that showed resistant to 3rd generation
cephalosporins (i.e., ceftriaxone in this study) with MIC
≥4 based on the E-test strip results were further screened
for extended-spectrum beta-lactamase (ESBL) production
via the Double Disc Synergy Test (DDST) as described
elsewhere [37]. Briefly, E. coli isolates from blood agar
plate were suspended in 0.85% saline to achieve an inocu-
lum equivalent to 0.5 McFarland standard as described
earlier. The suspension was then plated on an MH agar
plate and a disc containing amoxicillin-clavulanate (20/
10 μg, BD- Sensi Disc™) was placed in the center of the
plate. Next, one disc of ceftriaxone (30 μg, BD- Sensi
Disc™) and another disk of ceftazidime (30 μg, BD- Sensi
Disc™) were placed 15 mm apart from the edge of
amoxicillin-clavulanate disc as shown in Fig. 1. The cefox-
itin (30 μg, BD- Sensi Disc™) disc was placed in any avail-
able space remaining on the plate [37, 38]. The MH plates
with the four antibiotic discs were incubated at 37 °C for
18–24 h. Any E. coli isolate that showed an increase in the
zone of inhibition around either ceftazidime or ceftriaxone
(i.e., > 5 mm towards the disc of amoxicillin-clavulanate)
together with susceptibility to cefoxitin was interpreted as
positive for the ESBL production. Escherichia coli ATCC®
51,446 and 25,922 were used as control strains for positive
and negative ESBL production, respectively.
Data analysis
The antibiotic resistance outcomes (resistance or suscep-
tible [i.e., binary]) and multidrug-resistant (MDR)
Table 1 Minimum inhibitory concentration (MIC) range and interpretation for antibiotics used to test susceptibility of E. coli isolates
(n = 78) from food handlers’ fecal samples
Antibiotic Abbreviation MIC range tested (μg/mL) MIC Interpretive Standard (μg/mL)a
S I R
Penicillin & Penicillin β-lactamase inhibitor combinations
Ampicillin AM 0.016–256 ≤8 16 ≥32
Amoxicillin/Clavulanic acid XL 0.016–256 ≤8/4 16/8 ≥32/16
Aminoglycosides
Gentamicin GM 0.016–256 ≤4 8 ≥16
Quinolone
Ciprofloxacin CI 0.002–32 ≤0.006 0.12–0.5 ≥1
Chloramphenicol
Chloramphenicol CL 0.016–256 ≤8 16 ≥32
Tetracycline
Tetracycline TC 0.016–256 ≤4 8 ≥16
Folate pathway inhibitors
Trimethoprim TR 0.002–32 ≤8 – ≥16
Sulphamethoxazole SX 0.064–1024 ≤258 ≥512
Cephalosporin
Ceftriaxone TX 0.016–256 ≤1 2 ≥4
a The MIC values interpretation into sensitive (S), intermediate (I), and resistant (R) was according to the Clinical & Laboratory Standards Institute (CLSI) guidelines
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isolates (those resistant to three or more antimicrobial
classes) were cross tabulated with nationality using a
Fisher’s exact test or 2-by-n likelihood ratio chi-square
test, as appropriate, in STATA 14.1 software (Stata
Corp., College Station, TX).
Results
From the 456 food handler fecal samples tested, 78
(17.1%) were positive for E. coli. In general, isolates were
frequently resistant to sulfamethoxazole (33.3%),
followed by ampicillin (32.1%), trimethoprim (30.8%),
and tetracycline (25.6%). The E. coli isolates were less re-
sistant to ciprofloxacin (14.2%), ceftriaxone (9%), and
chloramphenicol (3.9%).
The distribution of E. coli isolates by nationality is
shown in Table 2. The individual antibiotic resistant E.
coli frequencies were not significantly (P > 0.05) different
by nationality. The antibiotic resistance profiles among
the 78 E. coli isolates are summarized in Table 3. The
distribution of phenotypic antibiotic resistance to the 9
antibiotics is shown in Fig.2. Approximately, 59% of the
isolates were resistant to at least one antibiotic, whereas
11.5, 15.4%, 11.5, 11.5, 6.4 and 2.6% isolates showed re-
sistance to one, two, three, four, five and six antibiotics,
respectively (Fig. 2). Twenty-seven percent (n = 78) of all
Fig. 1 Double Disc Synergy Test (DDST) confirming ESBL-Producing
E. coli isolates from fecal samples of food handlers (Antibiotic discs
and concentrations used were as follows: 1. Ceftazidime (30 μg); 2.
Amoxicillin/Clavulanic acid (20/10 μg); 3. Ceftriaxone (30 μg); and 4.
cefoxitin (30 μg))
Table 2 Distribution of fecal E. coli isolates (n = 78) by food
handler’s nationality
Nationality Frequency Percentage a
Indian 30 38.5
Bangladesh 19 24.4
Nepalese 13 16.7
Philippine 8 10.3
Indonesian 3 3.8
Kenyan 2 2.6
Siri Lankan 2 2.6
Thai 1 1.3
a Percentages of antibiotic resistant E. coli isolates by nationality were not
significantly different (P > 0.05) based on chi-square test in STATA
14.1 software
Table 3 Phenotypic resistant profiles of E. coli isolates from
food handlers’ fecal samples (n = 78)
Resistant phenotype Frequency Percentage
c
No resistance 32 41
Resistant to only one antibiotic 9 11.5
Trimethoprim; Sulfamethoxazole 5 6.4
Ampicillin; Trimethoprim; Sulfamethoxazole 4 5.12
a b Ciprofloxacin; Ampicillin; Ceftriaxone;
Trimethoprim; Sulfamethoxazole; Tetracycline
2 2.6
a Trimethoprim; Sulfamethoxazole;
Tetracycline; Ampicillin
3 3.8
a Tetracycline; Ciprofloxacin; Trimethoprim;
Sulfamethoxazole
3 3.8
a Ampicillin; Trimethoprim; Sulfamethoxazole;
Tetracycline; Ciprofloxacin
2 2.6
a b Ampicillin; Trimethoprim; Ceftriaxone;
Tetracycline; Ciprofloxacin
1 1.3
a Chloramphenicol; Sulphamethoxazole;
Tetracycline
2 2.6
a Ampicillin; Trimethoprim; Tetracycline 2 2.6
b Ampicillin; Ceftriaxone 2 2.6
Ampicillin; Tetracycline 2 2.6
Ampicillin; Trimethoprim 1 1.3
Trimethoprim; Tetracycline 1 1.3
Trimethoprim; Sulfamexazole; Ciprofloxacin 1 1.3
Ampicillin; trimethoprim; Sulfamethxazole;
Amoxcicillin-Clavulanic acid
1 1.3
Ampicillin; Sulfamethoxazole 1 1.3
a b Ampicillin; Sulfamethoxazole; Ceftriaxone;
Ciprofloxacin
1 1.3
a Ampicillin; Trimethoprim, Sulfamethoxazole;
Ciprofloxacin
1 1.3
a b Ampicillin; Tetracycline; Trimethoprim;
Sulfamethoxazole; Ceftriaxone
1 1.3
Ampicillin; Chloramphenicol; Tetracycline;
Trimethoprim; Sulfamethoxazole
1 1.3
MDR multi drug resistant, ESBL extended spectrum beta lactamase producer
aMDR (n = 19)
bESBL isolates; ESBL + MDR (21)
cPercentages of phenotypic resistant profiles of E. coli were significantly
different (P < 0.05) based on chi-square test in STATA 14.1 software
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E. coli isolates were multi drug resistant (MDR). More-
over, 9% (seven) of the E. coli isolates (n = 78) were ESBL
producers; of which five were MDR isolates.
Discussion
The incidence of AR bacteria in public hospital and
clinics is monitored by the Hamad Medical Corporation
(HMC), which is Qatar’s main health care provider.
According to recent reports by HMC, a notable increase
in the incidence of AR bacteria in individuals attending
out- and in-patient facilities has been observed [39, 40].
However, there are limited AR bacteria data on individ-
uals in non-hospital (i.e., community) settings such as
food handlers. To the best of our knowledge, this is the
first study to investigate the prevalence of AR enteric E.
coli in apparently healthy food handlers. In this pilot
study, we reported remarkable percentages of E. coli iso-
lates resistant to at least one antibiotic (i.e., 59%) with
27% being MDR and 9% being ESBL producing isolates.
The majority of the food handlers in this study had li-
mited knowledge of risk associated with food contamin-
ation (personal communication with the Medical
Commission staff ). This group may harbor and shed AR
enteric E. coli bacteria that can contaminate food pre-
pared for and consumed by people in Qatar. Thus, these
findings suggest that resistant E. coli isolates are present
in the community; hence, aggravating the public health
concerns regarding the spread of AR bacteria. A
one-health approach ought to be considered to address
this food safety and public health problem.
There are over 1300 food service establishments (res-
taurant and hotels) in Qatar that employ more than
50,000 workers with the majority being food handlers
[41]. Food handlers have been linked to large number of
foodborne outbreaks worldwide. The majority of food-
borne outbreaks associated with food services are due to
unsanitary conditions of the food handlers [17, 18] .
Therefore, they can easily contaminate the food they
handle with pathogens and non-pathogens. In agreement
with our findings, several studies have shown that
multi-drug resistant E. coli including commensal isolates
harboring ESBLs can be present in healthy individuals
[42–44]. Garedew-Kifelew L, Wondafrash N and Feleke
A [45] examined stool specimens of food handlers from
Ethiopia and revealed that 3.1% of the subjects were in-
fected with AR Salmonella. Similarly, Greig JD, Todd
EC, Bartleson CA and Michaels BS [46] concluded that
most of the foodborne outbreaks were associated with
food handlers who were asymptomatic carrier and ex-
crete the pathogen unknowingly while working, or they
were sick but continue to prepare food.
One of the limitations of this study was the low
recovery percentage of E. coli from fecal sample (~
17%) which could be due to the long storage of fecal
samples in − 20 °C over 2 year period and the direct
plating method of the samples on the selective
medium. Another limitation was that the sample col-
lection was from the participants conducted as part
of another research study that focused on presence
of enteric parasites; hence, we had no control over
the sampling scheme. Moreover, the results regarding
the AR E. coli by nationality need to be interpreted
with caution as the number of isolates from some
nationalities was low.
Fig. 2 Frequency bar chart illustrating the distribution of phenotypic antibiotic resistance to up to six antibiotics among E. coli isolates
(n = 79) from food handlers’ fecal samples in Qatar
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Conclusions
In conclusion, food handlers that are apparently healthy
individuals could harbor and shed AR enteric E. coli,
posing a significant public health risk to the general
population in Qatar. This may occur via dissemination
of AR E. coli through contaminated food. Despite the
potential effect encountered by the transmission of the
opportunistic bacteria through food handlers, this is the
first pilot study to screen the AR E. coli among appar-
ently healthy food handlers. More research studies are
needed to longitudinally follow AR commensal and
pathogenic bacteria in food handlers and the relationship
with unique and common strains found in hospital
settings. A better infection control and improved food
safety plans could reduce the risk of AR bacteria
contamination of food in Qatar. This could be through
delivering proper training to food handlers in order to
prevent the contamination of foods. In addition,
one-health approach with collaboration between food
safety, public health, and veterinary service entities can
further address this concern.
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